GLP1R agonists in NAFLD: a promising therapy on the horizon
Nat Rev Gastroenterol Hepatol
.
2023 Jun;20(6):346.
doi: 10.1038/s41575-023-00770-7.
Author
Rula Bany Bakar
1
Affiliation
1
Wellcome Trust-MRC Institute of Metabolic Science Metabolic Research Laboratories, University of Cambridge, Cambridge, UK. rtb44@medschl.cam.ac.uk.
PMID:
36977795
DOI:
10.1038/s41575-023-00770-7
No abstract available
MeSH terms
Humans
Hypoglycemic Agents / therapeutic use
Non-alcoholic Fatty Liver Disease* / drug therapy
Substances
Hypoglycemic Agents